Online self-help for females with bulimia and binge eating disorder
People with bulimia nervosa or binge eating disorder often wait a long time for effective treatment. Here we are trying to bridge this gap by providing people with different types of online treatment/support. We are conducting a randomised controlled trial (RCT) of the everyBody Plus online intervention compared to online symptom monitoring, in a sample of 138 females in the United Kingdom.
Who can take part?
1. Female participants over 18 years old diagnosed with Bulimia Nervosa or Binge Eating Disorder,
2. Fluent in English
3. Do not have a BMI under 18.5kg/m2
4. Adult females who are currently receiving face-to-face treatment for their eating disorder are not eligible for the study
This study involves:
1. A 15 minute phone call screening with study researcher
2. Self-enrolment on study website
3. Entering the frequency of eating disorder symptoms once a week for 12 months
4. Completing 4 online questionnaire assessment sessions over 12 months
5. Participants who are randomly assigned to the intervention condition will additionally have access to the online modules; 8 weekly sessions for 8 consecutive weeks, which will take approximately 60 minutes each. This involves writing journal entries and posting thoughts/questions on the online discussion forum. Once a week, they will receive personalised email feedback from a trained online therapist.
All participants across both conditions of the study will be awarded points for each completed weekly symptom logging and 4 questionnaire assessments over 12 months. Participants can earn a maximum number of 92 points (€92), which will be converted into pounds and paid via vouchers upon completion of the study.
Contact Vanessa Yim vanessa.yim@kcl.ac.uk for more details.
I am a research worker in Kings College London, Section of Eating Disorders. I help run an EU-funded clinical trial looking at the use of the online guided self-help for adult females with binge eating and bulimia. This targets at females who are seeking treatment or are currently on the waiting list as the study aims to bridge the waiting time gap.
Thank you for reading this! Look forward to hearing back from you.
